What is the role of valrubicin (Valstar) in the treatment of bladder cancer?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print
Answer

Patients with BCG-refractory CIS may also be treated with intravesical valrubicin (Valstar), which is currently the only FDA-approved agent for this particular indication. However, any patient who has persistent or recurrent disease after BCG should be considered for radical cystectomy, given the high rate of disease progression.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!